Aldesleukin

Aldesleukin
Trade Name Proleukin
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 1998-07-31 00:00:00
Sponsor Chiron Corporation;4560 Horton St.;Emeryville, California, 94608
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia